Found: 6
Select item for more details and to access through your institution.
Liquid chromatographic assay for the non-peptidic protease inhibitor tipranavir in plasma.
- Published in:
- Biomedical Chromatography, 2006, v. 20, n. 8, p. 671, doi. 10.1002/bmc.667
- By:
- Publication type:
- Article
Liquid chromatographic assay for the protease inhibitor atazanavir in plasma.
- Published in:
- Biomedical Chromatography, 2006, v. 20, n. 1, p. 72, doi. 10.1002/bmc.530
- By:
- Publication type:
- Article
Development and validation of a population pharmacokinetic model for ritonavir used as a booster or as an antiviral agent in HIV-1-infected patients.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 59, n. 2, p. 174, doi. 10.1111/j.1365-2125.2004.02241.x
- By:
- Publication type:
- Article
Practical guidelines to interpret plasma concentrations of antiretroviral drugs.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Drug-Drug Interaction between Itraconazole and the Antiretroviral Drug Lopinavir/Ritonavir in an HIV-1--Infected Patient with Disseminated Histoplasmosis.
- Published in:
- Clinical Infectious Diseases, 2004, v. 38, n. 8, p. e73, doi. 10.1086/382675
- By:
- Publication type:
- Article